TickerFactsScreenerDevelopers

BioXcel Therapeutics, Inc. (BTAI) — Revenue

Annual figures by fiscal year, from SEC filings.

2022: $375.0K2023: $1.38M2024: $2.27M2025: $642.0K$642.0K
2022Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$642.0K-71.7%
2024$2.27M+64.2%
2023$1.38M+268.0%
2022$375.0K—